Hi Pivalde,
I think Margaret Bradbury has strong ties to NY, being based with Salk
Margaret Bradbury, Vice President, Nonclinical Development Alterity TherapeuticsAlterity Therapeutics (Formerly Prana Biotechnology)Salk Institute for Biological StudiesNew York, New York, United States
NEW PAPER about ATH434 and endothelial cells !!!!, page-19
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $67 | 13.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 40123044 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 17787904 | 20 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
0.000 ( 10.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.6¢ | 0.5¢ | 4997767 | ||
| Last updated 15.10pm 24/05/2024 ? | |||||
| ATH (ASX) Chart |